non targeting dsrna Search Results


  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 88
    ALZA non targeting dsrna
    Non Targeting Dsrna, supplied by ALZA, used in various techniques. Bioz Stars score: 88/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/non targeting dsrna/product/ALZA
    Average 88 stars, based on 8 article reviews
    Price from $9.99 to $1999.99
    non targeting dsrna - by Bioz Stars, 2020-09
    88/100 stars
      Buy from Supplier

    85
    Thermo Fisher non targeting control dsrna
    Non Targeting Control Dsrna, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 85/100, based on 13 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/non targeting control dsrna/product/Thermo Fisher
    Average 85 stars, based on 13 article reviews
    Price from $9.99 to $1999.99
    non targeting control dsrna - by Bioz Stars, 2020-09
    85/100 stars
      Buy from Supplier

    85
    Thermo Fisher stability enhanced non targeting dsrna control oligonucleotide
    Stability Enhanced Non Targeting Dsrna Control Oligonucleotide, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 85/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/stability enhanced non targeting dsrna control oligonucleotide/product/Thermo Fisher
    Average 85 stars, based on 8 article reviews
    Price from $9.99 to $1999.99
    stability enhanced non targeting dsrna control oligonucleotide - by Bioz Stars, 2020-09
    85/100 stars
      Buy from Supplier

    85
    Horizon Discovery non targeting double stranded rna dsrna construct
    Non Targeting Double Stranded Rna Dsrna Construct, supplied by Horizon Discovery, used in various techniques. Bioz Stars score: 85/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/non targeting double stranded rna dsrna construct/product/Horizon Discovery
    Average 85 stars, based on 3 article reviews
    Price from $9.99 to $1999.99
    non targeting double stranded rna dsrna construct - by Bioz Stars, 2020-09
    85/100 stars
      Buy from Supplier

    85
    Horizon Discovery i fect encapsulated non targeting dsrna
    A. Experimental design. (Ith: Intrathecal; siRNA: Raf-1 siRNA or mismatch siRNA delivery via intrathecal catheter; BL: Baseline; D: Day; IR: Infrared heat). B. Raf-1 siRNA attenuates sustained morphine-mediated thermal hyperalgesia in rats: Male Sprague Dawley rats received intrathecal injections of <t>i-Fect</t> encapsulated Raf-1selective siRNA (Raf-1 siRNA groups); or non-targeting <t>dsRNA</t> (mismatch siRNA groups) or the transfection agent (i-Fect) alone (control) once daily, for 3 days. After pre-treatment, the rats received continous subcutaneous (osmotic minipump) saline (control group, Raf-1 siRNA group and mismatch siRNA group) or morphine (45μg/μl/h) (morphine group, Raf-1 siRNA+morphine group and mismatch siRNA+morphine group) infusions for 6 days. Six animals were included in each treatment group. Thermal hyperalgesia was measured as a decrease in paw withdrawal latencies in a radiant heat paw-withdrawal test.
    I Fect Encapsulated Non Targeting Dsrna, supplied by Horizon Discovery, used in various techniques. Bioz Stars score: 85/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/i fect encapsulated non targeting dsrna/product/Horizon Discovery
    Average 85 stars, based on 3 article reviews
    Price from $9.99 to $1999.99
    i fect encapsulated non targeting dsrna - by Bioz Stars, 2020-09
    85/100 stars
      Buy from Supplier

    Image Search Results


    A. Experimental design. (Ith: Intrathecal; siRNA: Raf-1 siRNA or mismatch siRNA delivery via intrathecal catheter; BL: Baseline; D: Day; IR: Infrared heat). B. Raf-1 siRNA attenuates sustained morphine-mediated thermal hyperalgesia in rats: Male Sprague Dawley rats received intrathecal injections of i-Fect encapsulated Raf-1selective siRNA (Raf-1 siRNA groups); or non-targeting dsRNA (mismatch siRNA groups) or the transfection agent (i-Fect) alone (control) once daily, for 3 days. After pre-treatment, the rats received continous subcutaneous (osmotic minipump) saline (control group, Raf-1 siRNA group and mismatch siRNA group) or morphine (45μg/μl/h) (morphine group, Raf-1 siRNA+morphine group and mismatch siRNA+morphine group) infusions for 6 days. Six animals were included in each treatment group. Thermal hyperalgesia was measured as a decrease in paw withdrawal latencies in a radiant heat paw-withdrawal test.

    Journal: European journal of pharmacology

    Article Title: Intrathecal Raf-1-selective siRNA attenuates sustained morphinemediated thermal hyperalgesia

    doi: 10.1016/j.ejphar.2008.10.033

    Figure Lengend Snippet: A. Experimental design. (Ith: Intrathecal; siRNA: Raf-1 siRNA or mismatch siRNA delivery via intrathecal catheter; BL: Baseline; D: Day; IR: Infrared heat). B. Raf-1 siRNA attenuates sustained morphine-mediated thermal hyperalgesia in rats: Male Sprague Dawley rats received intrathecal injections of i-Fect encapsulated Raf-1selective siRNA (Raf-1 siRNA groups); or non-targeting dsRNA (mismatch siRNA groups) or the transfection agent (i-Fect) alone (control) once daily, for 3 days. After pre-treatment, the rats received continous subcutaneous (osmotic minipump) saline (control group, Raf-1 siRNA group and mismatch siRNA group) or morphine (45μg/μl/h) (morphine group, Raf-1 siRNA+morphine group and mismatch siRNA+morphine group) infusions for 6 days. Six animals were included in each treatment group. Thermal hyperalgesia was measured as a decrease in paw withdrawal latencies in a radiant heat paw-withdrawal test.

    Article Snippet: After recovery from the surgery (5–7 days), the animals received intrathecal injections (2ug siRNA/10 ul/rat) of either a lipid encapsulated Raf-1-selective siRNA mixture (Smart pool siRNA, Dharmacon Inc; Chicago, IL, Cat # L-087699-00 ) (Raf-1 siRNA groups) or i-Fect encapsulated non-targeting dsRNA (Dharmacon, # D-001810-01-20 ) (control mismatch siRNA groups) or the transfection lipid alone, once daily, for 3 days, as described earlier ( ).

    Techniques: Transfection